Effects of Subanesthetic Concentrations of Nitrous Oxide - 1
NCT ID: NCT00000249
Last Updated: 2015-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
10 participants
INTERVENTIONAL
1993-09-30
1995-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Acute Treatment With N2O on Inhibitory Pain Mechanisms in Healthy Subject
NCT01616004
Combination of Nitrous Oxide 70% With Fentanyl Intranasal for Procedural Analgosedation in Children
NCT02533908
Lumbar Puncture in Emergency Under Nitrous OXide
NCT03941990
Nitrous Oxide for Lumbar Puncture
NCT03228628
Effectiveness of Nitrous Oxide in the ED
NCT02703233
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Subject inhaled 0% N2O for 40 minutes with cold immersion at 10 and 30 minutes
No interventions assigned to this group
20% N2O
Subject inhaled 20% N2O for 40 minutes with cold immersion at 10 \& 30 minutes
20% N2O
20% inhaled N2O
30% N2O
Subject inhaled 30% N2O for 40 minutes with cold immersion at 10 and 30 minutes
30% N2O
30% inhaled N2O
40% N2O
Subject inhaled 40% N2O for 40 minutes with cold immersion at 10 and 30 minutes
40% N2O
40% inhaled N2O
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
20% N2O
20% inhaled N2O
30% N2O
30% inhaled N2O
40% N2O
40% inhaled N2O
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
21 Years
37 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
University of Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James Zacny, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Chicago
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Chicago, Anesthesia & Critical Care
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Pharmocol Biochem and Behavior 1995, 51( 2): 323-329
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R01-08391-1
Identifier Type: -
Identifier Source: secondary_id
NIDA-08391-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.